Antibody-dependent cellular cytotoxicity and direct cytotoxicity assays were performed with equine infectious anemia virus-infected target cells, equine leukocytes, and equine anti-equine infectious anemia virus antibody to determine whether these mechanisms play a role in controlling viral replication in equine infectious anemia. Direct cytotoxicity was observed by using peripheral blood mononuclear cells from 7 of 10 infected horses. Antibody-dependent cellular cytotoxicity was not observed. The antibody-dependent cellular cytotoxicity reaction in horses was then studied by using sheep erythrocytes and trinitrophenylated sheep erythrocytes as target cells. Lysis of these target cells was mediated by neutrophils, monocytes, and lymphocytes. The reaction was activated by antibody of the immunoglobulin G class but not by immunoglobulin G(T). Furthermore, immunoglobulin G(T) efficiently inhibited immunoglobulin G in this function.
frequency, and severity of cycles vary among horses. Most horses, however, stop cycling within a few months and become asymptomatic viral carriers for life. The control of viral replication and, consequently, clinical disease seems to be immunological in nature (Crawford et al., in press).
We hypothesized that antibody-dependent cellular cytotoxicity (ADCC) and direct cytotoxicity would be operative in horses with EIA. Furthermore, factors which modulate these mechanisms might contribute to differences in clinical patterns among infected horses. In this study we tested the ability of horse leukocytes, in the presence and absence of antibody, to kill EIA virus-infected target cells. We found that peripheral blood mononuclear cells (PBMC) from infected horses selectively killed virus-infected cells in direct cytotoxicity assays. However, attempts to demonstrate ADCC were unsuccessful. This prompted an attempt to more thoroughly define the ADCC phenomenon in horses by using defined antigens and purified reagents. We found that ADCC in horses is mediated by neutrophils, monocytes, and lymphocytes, is activated by antibodies of the immunoglobulin G (IgG) class, and is inhibited by antibodies of the IgG(T) subclass. 1640 with 10% fetal calf serum and incubated on plastic petri plates at 370C for 2 h. Nonadherent lymphocytes were removed by gentle aspiration. The plates were washed vigorously with RPMI 1640, and any additional nonadherent cells were discarded. Monocytes were then scraped from the plates. Mononuclear eMlls were also separated by passage over nylon wool columns. The columns were prepared and eluted as previously described, except that Hanks balanced salt solution was substituted for Puck solution G (49) .
Neutrophils were obtained by collecting the cells that pelleted through Ficoll-Hypaque and lysing the erythrocytes with 0.83% ammonium chloride. They were washed three times with RPMI 1640 containing 5% fetal calf serum.
Suspensions of isolated monocytes, neutrophils, and lymphocytes were adjusted to a density of 107 cells per, ml of RPMI 1640 with 5% fetal calf serum. The respective cell preparations contained >98% neutrophils, >95% lymphocytes, and >95% monocytes, as defined by morphological criteria on Wright-stained smears.
Target cells. Equine dermal fibroblasts persistently infected with the fibroblast-adapted strain of EIA virus (33) were produced as previously described (10) . Noninfected dermal fibroblasts were maintained under identical conditions. Sheep erythrocytes (SRBC) and trinitrophenylated SRBC (TNP-SRBC) were also used as target cells. Fresh SRBC were washed three times with RPMI 1640 and resuspended at a concentration of 5 x 105 cells per ml. TNP-SRBC were prepared as previously described (47) .
Antisera. Horse anti-SRBC, prepared by repeated intravenous injections of washed SRBC, had agglutinating and hemolytic titers of 1:16 and 1:1,000, respectively. Anti-2,4-dinitrophenol (DNP) antibody was prepared by immunization of horses with DNP-bovine gamma globulin as previously described (34) . Anti-DNP antibodies were obtained by affinity chromatography on a DNP-lysine-agarose column and subsequently fractionated into IgG and IgG(T) by diethylaminoethyl-cellulose chromatography (34) . Sera from horses infected with the Wyoming strain of ETA virus were used as sources of anti-EIA virus antibody. Measurement of direct cytotoxicity by "Cr release. The assay was performed in flat-bottomed microtiter plates (Falcon Plastics, Oxnard, Calif.) as follows. Effector cells were dispersed in 0.1-ml volumes in three wells; this was followed by the addition of 0.1 ml of labeled target cells. After incubation at 370C for 34 h, the plates were centrifuged, and 0. Ability of antibody type to activate lysis of SRBC by ADCC. The ability of IgG and IgG(T) antibodies to participate in ADCC was tested. Varying quantities of IgG(T) were added to 0.1 ml of effector cells in microtiter wells, and TNP-SRBC were then added. After 4 h at 370C, cytotoxicity was evaluated as described above. The ability of IgG(T) to inhibit IgG-mediated ADCC was tested by using anti-DNP IgG and IgG(T) in three different ratios of IgG(T) to IgG (7.78, 1, and 0.124; see Table 4 ). For each experiment, IgG anti-DNP was first incubated with TNP-SRBC for 5, 10, 15, 30, 60, and 120 min. IgG(T) and effector cells were then added, and cytotoxicity was evaluated after 4 h. In parallel experiments, the same protocol was followed, except that the IgG and IgG(T) were reversed.
RESULTS
Demonstration of direct cytotoxicity with EIA virus-infected target cells. Direct cytotoxicity reactions were demonstrated by using PBMC from three horses infected with ETA virus. The magnitude of cytotoxicity was dependent on the ratio of effector cells to target cells (Fig. 1) . Cytotoxicity was reproducibly observed at ratios of effector cells to target cells of 100:1. Cytotoxicity from control horse PBMC was negligible at this ratio. Therefore, a ratio of 100:1 was used for subsequent studies. The in vitro kinetics of cytotoxicity were examined by using PBMC obtained from three infected horses and one control horse. The release of 5"Cr increased with time in the presence of PBMC from both normal and EIA virus-infected horses (Fig. 2) . A 34-h harvest time provided both convenience and an acceptable ratio between release by infected horse PBMC and release by control horse PBMC. Table 1 summarizes the results obtained when PBMC from 10 infected horses were evaluated in cytotoxicity assays. Positive responses were obtained 14 to 18 days after infection of four horses with 5 x 107 50% tissue culture infective doses of the fibroblast-adapted strain of EIA virus. Three of six horses infected for 1 to 11 years also had cytotoxic PBMC detectable by this assay.
Absence of ADCC with EA virus-infected target cells. The ability of equine leukocytes to mediate ADCC reactions against EIA virus-infected fibroblasts was examined (Tables  2 and 3 ). Leukocytes from three control and eight infected horses and anti-EIA antibody from eight horses were used. No ADCC could be demonstrated.
Characterization of ADCC reactions in horses employing defined antigens and purified reagents. Neutrophils (polymorphonuclear leukocytes [PMN] ), PBMC, monocytes, and lymphocytes from control horses and horses infected with EIA virus were compared in ADCC assays by using SRBC targets sensitized with horse anti-SRBC antibody (Fig. 3) . All cell preparations were active in ADCC, and the order of effectiveness was PMN > monocytes > lymphocytes. No obvious differences in effector cell activity between EIA virus-infected and control horses were observed.
PBMC from control and infected horses were separated into adherent and nonadherent subpopulations by passage over nylon wool columns. The activity of adherent and nonadherent cells in ADCC assays was similar to that of unfractionated PBMC (data not shown).
The influence of the ratio of effector cells to target cells was evaluated (Fig. 4) hibition depended on the ratio of IgG to IgG(T) and on the order of addition of antibody to target cells. IgG(T) significantly inhibited ADCC (more than 50%) when it was present in onetenth the amount of IgG and was added as much as 30 min after IgG (Table 4 , experiment 3).
Based on the marked inhibition of ADCC by IgG(T) when TNP-SRBC were used as target cells, we attempted to determine whether the presence of IgG(T) caused inhibition of ADCC by using EIA virus-infected fibroblasts as target cells. IgG was fractionated from sera of four horses infected with EIA virus. None of the IgG fractions was entirely pure, as all contained at least 10% IgG(T 23 and a noninfected control horse.
VOL. 24, 1979 on October However, 14 to 18 days after these same horses were infected with EIA virus, their PBMC were able to specifically lyse EIA virus-infected target cells. And second, interferon was not demonstrated in horses or cell cultures infected with EIA virus (30) . Furthermore, it has been shown in one outbred species that genetic compatibility between effector and target cells is not required for T-lymphocyte-mediated cytotoxicity of virus-infected cells (50) . Therefore, the cytotoxicity observed in our studies was most likely mediated by T lymphocytes. Absence of defined markers for horse T lymphocytes, however, prevented rigorous proof of this mechanism. Our inability to demonstrate ADCC reactions with EIA virus-infected fibroblast target cells prompted us to further investigate the ADCC phenomenon in horses. The results indicated that nonsensitized equine leukocytes, in the presence of specific antibodies of the IgG class, are capable of mediating ADCC reactions. Neutrophils were most active, exceeding monocytes and lymphocytes in cytotoxic potential. Activity of leukocytes from uninfected horses or horses with asymptomatic EIA was similar. This lack of suppression of leukocyte activity during asymptomatic EIA is consistent with previous studies (3, 4) . However, others have claimed that transient suppression occurs in the early stages of the disease (25) .
Our results also are consistent with studies in other species, in which IgG predominates in ADCC reactions (43, 44, 48, 56, 57, 60) , although IgM is effective in some systems (8, 28, 29 a TNP-SRBC target cells were incubated with IgG or IgG(T) anti-DNP antibody for 5 to 120 min, after which time effector cells with or without additional anti-DNP antibody were added. G -* T, IgG was added before IgG(T); T + G, IgG(T) and IgG were added simultaneously; T -s G, IgG(T) was added before IgG.
Effector cells were added 5 to 120 min later. Cultures were incubated for 4 h, and percent specific release of 51Cr was determined.
showed that herpesvirus-infected target cells could be lysed by bovine monocytes and PMN but not by lymphocytes. However, all three bovine effector cell types were able to lyse chicken erythrocyte targets. In our studies with EIA virus-infected target cells, neutrophils and a mixture of lymphocytes and monocytes showed no ADCC. (iii) The sera used in our studies may have lacked antibody with sufficient specificity for target cell membrane antigens. A new antigenic variant of EIA virus appears in the blood of horses with each new clinical cycle (24) . It is possible that this antigenic variation is reflected in cell membrane antigens as well. Although sufficient quantities of antibody are bound to allow detection by radioimmunoassay (36), they may be insufficient to trigger ADCC. (iv) A final possible explanation is inhibition by IgG(T). Sufficient specific antibody of the IgG(T) subclass may have been present in all sera tested to inhibit the reaction. To verify this possibility, IgG(T)-free antisera would be required. Since our purest preparations of IgG from sera of horses infected with EIA virus contained approximately 10% IgG(T), this question could not be resolved with available reagents. However, if the efficiency of inhibition by IgG(T) using TNP-erythrocytes is applicable to other antigen systems, the ADCC reaction does not seem likely to be very consequential in vivo. Therefore, if cellular mechanisms are involved in the control of EIA virus replication, it appears that direct cytotoxicity is more important than ADCC.
